NCT06377449

Brief Summary

The goal of this interventional is to assess advantages of the ultrasound examination of the lungs in the early postoperative period in cardiac surgical patients after heart surgeries requiring cardiopulmonary bypass. Evaluation of pulmonary complications and outcomes during mid-term follow-up, as well as comparison of ultrasound examination and traditional roentgenologic methods (X-ray examination and CT of the chest) will be performed. The main question\[s\] it aims to answer are:

  • Is ultrasound examination of the lungs a more specific and sensitive method in identification of early postoperative pulmonary complications after on-pump cardiac surgical procedures, in comparison with traditional X-ray methods.
  • Does early identification of interstitial pulmonary edema (based on number of visualised B-lines in the early postoperative period), influences mid-term outcomes in this cohort of patients Participants will undergo ultrasound examination of the lungs on postoperative day 1, 3, 5 and 7 after heart surgery. Based on ultrasound findings and degree of interstitial pulmonary edema, medical (diuretics, anti-inflammatory, e.t.c) therapy will be modified. Researchers will compare this group of patients with control group, in which ultrasound examination will be performed in the same time frames, but no changes in medical management based on ultrasound findings will be made to see if timely administered medical therapy, based on ultrasound findings, can significantly improve symptoms, hospital lengths of stay and outcomes of this patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
186

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 22, 2024

Completed
23 days until next milestone

Study Start

First participant enrolled

May 15, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

December 9, 2024

Status Verified

December 1, 2024

Enrollment Period

1 year

First QC Date

November 27, 2023

Last Update Submit

December 4, 2024

Conditions

Keywords

Ultrasound examination of the lungsB-linesCoronary artery bypass graftingHeart valve surgeryCardiopulmonary bypassOn-pump cardiac surgery

Outcome Measures

Primary Outcomes (1)

  • The number of participants with interstitial pulmonary edema at the day of hospital discharge, according to ultrasound lung examination

    Participants with more than three B-lines according to ultrasound lung examination (BLUE protocol) at the day of hospital discharge

    Ultrasound lung examination every second day of hospital stay; from date of admission until hospital discharge or date of death from any cause, whichever came first, assessed up to 4 weeks

Secondary Outcomes (3)

  • Postoperative pulmonary complications

    Ultrasound lung examination every second day of hospital stay; from date of admission until hospital discharge or date of death from any cause, whichever came first, assessed up to 4 weeks

  • Cumulative dosage of diuretics

    Ultrasound lung examination every second day of hospital stay; from date of admission until hospital discharge or date of death from any cause, whichever came first, assessed up to 4 weeks

  • Number of nights at home after hospital discharge

    Ultrasound lung examination every second day of hospital stay; from date of admission until hospital discharge or date of death from any cause, whichever came first, assessed up to 4 weeks

Study Arms (2)

Medical management based on results of ultrasound lungs examination

EXPERIMENTAL

Based on the degree/ presence of interstitial pulmonary edema (number of B-lines) and presence of postoperative pleural effusion, identified by regularly performed ultrasound examination of the lungs, medical therapy will be modified in each particular patient to improve clinical status and outcome. Administration of the following drug groups can be made/ doses can be adjusted: Diuretics (furosemide/ Hypothiazide/ spironolactone), Non-steroid antiinflammatory (Ibuprofen), Glucocorticoids.

Diagnostic Test: Ultrasound examination of the lungs

Medical management based on routine clinical and X-ray diagnostic methods

ACTIVE COMPARATOR

Ultrasound examination of the lungs will be performed in all patients in this group, but the attending physician will not be informed about it's results and findings. Any changes in medical therapy/ treatment strategy will be based on standard clinical and X-ray diagnostic methods.

Diagnostic Test: Ultrasound examination of the lungs

Interventions

Experimental: Standard ultrasound examination of the lungs based on modified BLUE protocol Active Comparator: Standard ultrasound examination of the lungs based on modified BLUE protocol

Medical management based on results of ultrasound lungs examinationMedical management based on routine clinical and X-ray diagnostic methods

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • open heart surgery with cardiopulmonary bypass (CPB) between 15 December 2023 and 15 December 2024
  • signed informed consent for participation in the study

You may not qualify if:

  • reoperations on the open heart with CPB
  • surgical procedures on lungs and lung cancer in the anamnesis
  • chronic obstructive pulmonary disease, stage III
  • chronic kidney disease, stages 4 and 5
  • patients with low Risk Score profile by the Society of Thoracic Surgeons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Petersburg State University Clinic

Saint Petersburg, Sankt-Peterburg, 190020, Russia

RECRUITING

Related Publications (2)

  • Russell FM, Ehrman RR, Barton A, Sarmiento E, Ottenhoff JE, Nti BK. B-line quantification: comparing learners novice to lung ultrasound assisted by machine artificial intelligence technology to expert review. Ultrasound J. 2021 Jun 30;13(1):33. doi: 10.1186/s13089-021-00234-6.

    PMID: 34191132BACKGROUND
  • Lichtenstein D, Goldstein I, Mourgeon E, Cluzel P, Grenier P, Rouby JJ. Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome. Anesthesiology. 2004 Jan;100(1):9-15. doi: 10.1097/00000542-200401000-00006.

    PMID: 14695718BACKGROUND

MeSH Terms

Conditions

Myocardial IschemiaAortic Valve StenosisAortic Valve InsufficiencyMitral Valve StenosisMitral Valve InsufficiencyTricuspid Valve InsufficiencyAneurysm, Ascending Aorta

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesAortic Valve DiseaseHeart Valve DiseasesVentricular Outflow ObstructionAortic Aneurysm, ThoracicAortic AneurysmAneurysmAortic Diseases

Central Study Contacts

Aleksei A Filippov, MD, PhD

CONTACT

Sergey M Efremov, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, single-center study with 2 groups of patients (investigating and control arms)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
State Cardiovascular Surgeon

Study Record Dates

First Submitted

November 27, 2023

First Posted

April 22, 2024

Study Start

May 15, 2024

Primary Completion

May 15, 2025

Study Completion

January 1, 2026

Last Updated

December 9, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Individual participant data is not planned to be shared with other parties

Locations